High-dose, short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure

• Egile Nagusiak: Yabuno K (Egilea), Seki M (Egilea), Miyawaki K (Egilea), Miwa Y (Egilea), Tomono K (Egilea)
• Formatua: Liburua
• Argitaratua: Dove Medical Press, 2013-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Kaori Yabuno,1,2,* Masafumi Seki,1,* Koji Miyawaki,1,2 Yoshihiro Miwa,2 Kazunori Tomono11Division of Infection Control and Prevention, 2Department of Pharmacy, Osaka University Hospital, Osaka, Japan *These authors contributed equally to this workBackground: The recommended daptomycin dosage is 4 or...